Michael L. Meyers - Net Worth and Insider Trading
Michael L. Meyers Net Worth
The estimated net worth of Michael L. Meyers is at least $131,946 dollars as of 2024-09-21. Michael L. Meyers is the SVP, Chief Medical Officer of Syndax Pharmaceuticals Inc and owns about 7,222 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $131,946. Details can be seen in Michael L. Meyers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael L. Meyers has not made any transactions after 2019-03-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael L. Meyers
Michael L. Meyers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael L. Meyers owns 2 companies in total, including Syndax Pharmaceuticals Inc (SNDX) , and Nuvalent Inc (NUVL) .
Click here to see the complete history of Michael L. Meyers’s form 4 insider trades.
Insider Ownership Summary of Michael L. Meyers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2019-03-21 | SVP & Chief Development Officer |
| NUVL | Nuvalent Inc | 2022-10-04 | director |
Michael L. Meyers Latest Holdings Summary
Michael L. Meyers currently owns a total of 1 stock. Michael L. Meyers owns 7,222 shares of Syndax Pharmaceuticals Inc (SNDX) as of March 21, 2019, with a value of $131,946.
Latest Holdings of Michael L. Meyers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2019-03-21 | 7,222 | 18.27 | 131,946 |
Holding Weightings of Michael L. Meyers
Michael L. Meyers Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael L. Meyers has made a total of 0 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years. The most-recent trade in Syndax Pharmaceuticals Inc is the acquisition of 1,104 shares on March 21, 2019, which cost Michael L. Meyers around $5,432.
Insider Trading History of Michael L. Meyers
- 1
Michael L. Meyers Trading Performance
GuruFocus tracks the stock performance after each of Michael L. Meyers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael L. Meyers is 55.95%. GuruFocus also compares Michael L. Meyers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael L. Meyers within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael L. Meyers's insider trading performs compared to the benchmark.
Performance of Michael L. Meyers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.39 | | | | | |
| Relative Return to S&P 500(%) | 19.26 | | | | | |
Michael L. Meyers Ownership Network
Michael L. Meyers Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Michael L. Meyers is the SVP & Chief Development Officer of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Michael L. Meyers made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 264,275 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 347,852 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 346,602 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
Michael L. Meyers Mailing Address
Above is the net worth, insider trading, and ownership report for Michael L. Meyers. You might contact Michael L. Meyers via mailing address: C/o Syndax Pharmaceuticals, Inc., 400 Totten Pond Road, Suite 110, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
